发明名称 |
MODIFIED SMALL INTERFERING RNA MOLECULES AND METHODS OF USE |
摘要 |
The present invention provides double-stranded RNA molecules that mediate RNA interference in target cells, preferably hepatic cells. The invention also provides double-stranded RNA (dsRNA) molecules that are modified to be resistant to nuclease degradation, which inactivates a virus, and more specifically, hepatitis C virus (HCV). The invention also provides a method of using these modified RNA molecules to inactivate virus in mammalian cells and a method of making modified small interfering RNAs (siRNAs) using human Dicer. The invention provides modified RNA molecules that are modified to include a dsRNA or siRNA wherein one or more of the pyrimidines in the RNA molecule are modified to include 2′-Fluorine. The invention also provides dsRNA or siRNA in which all pyrimidines are modified to include a 2′-Fluorine. The invention provides that the 2′-Fluorine dsRNA or siRNA molecule is further modified to include a two base deoxynucleotide “TT” sequence at the 3′ end of the molecule. |
申请公布号 |
US2015361432(A1) |
申请公布日期 |
2015.12.17 |
申请号 |
US201514819606 |
申请日期 |
2015.08.06 |
申请人 |
Arrowhead Research Corporation |
发明人 |
Han Jang;Seo Mi-Young;Houghton Michael |
分类号 |
C12N15/113 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for inactivating Hepatitis C Virus (HCV) in a patient, the method comprising the step of administering to said patient a siRNA in an amount effective to inactivate said virus, wherein said siRNA comprises a first strand and a second strand, wherein the sequence of said first strand is SEQ ID NO: 46 and the sequence of said second strand is selected from the group of SEQ ID NO: 18 and SEQ ID NO: 45. |
地址 |
Pasadena CA US |